labelled staphylococcal protein A test were used to measure yersinia specific immune complexes and platelet reactive IgG respectively. The results obtained show for the first time the occurrence of bacterial antigens, derived from the causative strain, in the synovial fluid in yersinia triggered reactive arthritis.
The pathogenesis of yersinia triggered reactive arthritis remains unknown. HLA-B27 is known to be associated with the development of this postinfectious complication, and certain interesting features characterise the immune response of the patients.1 2 Determinations of IgM rheumatoid factor in synovial fluids taken from patients with yersinia triggered reactive arthritis were negative.
Discussion
Our findings indicate the existence of yersinia antigens in the form of ICs in the synovial fluid of patients with reactive arthritis after yersiniosis. We also believe that the occurrence of ICs containing yersinia antigens in the synovial fluid in reactive arthritis is more common than shown by the present study (in three out of 12 patients) since different methods detect different ICs.1" This holds true for the ELISA of yersinia specific ICs and for the PIPA. PIPA detects platelet reactive IgG, which consists in the serum of antigen-IgG complexes, IgG aggregates, and sometimes also specific antibodies, e.g., antiplatelet and anti-HLA antibodies. 12 For the ELISA of yersinia specific ICs that we used the antigen within the ICs must be exposed to be detected.8 Also, only one rabbit anti-yersinia serum was applied; use of antisera detecting other epitopes might have increased the number of positive samples. Therefore, synovial fluids positive only with a PIPA may contain yersinia antigens as well. A further possibility is that most of the yersinia specific ICs are phagocytosed by synovial fluid monocytes and granulocytes and are therefore not detectable in the supernatant.
The specificity of our findings is indicated by the absence of yersinia specific ICs in the synovial fluid of control patients. Nine of the controls were reactive arthritides triggered by factors other than yersiniae. Specificity of the assay has also been confirmed by inhibition experiments using Y enterocolitica 0:3 antigens3 and by dissociation of antigenantibody complexes.'3 Analysis by high pressure liquid chromatography of yersinia specific ICs in the sera of patients with yersiniosis has shown that they are relatively small in size. '3 Interestingly, two of the three patients with detectable yersinia specific ICs in the synovial fluid during the early stage of the disease continued to have joint symptoms for at least a year after the initial infection. This may indicate increased antigen load in these patients, leading to formation of yersinia specific ICs in such amounts that they become detectable by the present method. Also, in our earlier study prolonged joint symptoms were observed in five out of the six patients with yersinia triggered reactive arthritis, who still had circulating yersinia specific ICs over eight months after the onset of infection. 22 All these findings call into question definitions of postinfectious and reactive arthritis. Dumonde classifies arthritis as postinfectious when microbial antigen can be shown in the synovium or synovial fluid, and reactive in cases in which the microbial antigen is absent from the joint. 
